• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Riley Griffin

Stay informed with Riley Griffin’s coverage and analysis.

Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
FinanceJohnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
By Riley Griffin, John Lauerman and BloombergNovember 12, 2021
Moderna COVID-19 vials
HealthModerna defends its COVID-19 vaccine, acknowledges heart risks in young men
By Riley Griffin and BloombergNovember 11, 2021
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
HealthMerck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By Thomas Mulier, Riley Griffin and BloombergOctober 8, 2021
Regeneron antibody COVID treatment
HealthBiden administration moves to prevent shortage of COVID-19 antibody treatments
By Riley Griffin, Emma Court and BloombergSeptember 15, 2021
Moderna seeks full FDA approval for its COVID-19 vaccine
HealthModerna seeks full FDA approval for its COVID-19 vaccine
By Riley Griffin and BloombergAugust 25, 2021
Brainstorm Health 2020-Alex Gorsky
HealthJohnson & Johnson taps Duato as new CEO, replacing Gorsky
By Riley Griffin and BloombergAugust 20, 2021
Pfizer submits early data on the effects of third booster dose to FDA
HealthPfizer submits early data on the effects of third booster dose to FDA
By Riley Griffin, Robert Langreth and BloombergAugust 16, 2021
Pfizer to deliver 200 million vaccines to the U.S. in push to protect kids
HealthPfizer to deliver 200 million vaccines to the U.S. in push to protect kids
By Riley Griffin and BloombergJuly 23, 2021
J&J recalls some Neutrogena and Aveeno sunscreens after carcinogen found
EnvironmentJ&J recalls some Neutrogena and Aveeno sunscreens after carcinogen found
By Anna Edney, Riley Griffin and BloombergJuly 14, 2021
Johnson & Johnson says its COVID vaccine helps protect against the delta variant
HealthJohnson & Johnson says its COVID vaccine helps protect against the delta variant
By Riley Griffin and BloombergJuly 2, 2021
U.S. to invest $3.2 billion into COVID antiviral program
HealthU.S. to invest $3.2 billion into COVID antiviral program
By Riley Griffin, Rebecca Torrence and BloombergJune 17, 2021
Healthcare Workers Administer Covid-19 Vaccines At Airport As U.S. Daily Cases Hit 14-Month Low
HealthPfizer is launching a final study of the COVID-19 vaccine in children under 12
By Riley Griffin and BloombergJune 8, 2021
Merck takes huge hit for its abandoned COVID-19 drug efforts
HealthMerck takes huge hit for its abandoned COVID-19 drug efforts
By Riley Griffin and BloombergMay 6, 2021
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
LeadershipGlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
By James Paton, Riley Griffin and BloombergMarch 24, 2021
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
HealthTeva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By Riley Griffin and BloombergFebruary 10, 2021
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Economy
'The golden years are not golden': Boomers are hoarding most of America's wealth and power because they're terrified of outliving their moneyplaceholder alt text
By Nick LichtenbergJune 7, 2026
Success
Gen Zers are arriving to college unable to even read a sentence—professors warn it could lead to a generation of anxious and lonely graduatesplaceholder alt text
By Preston ForeJune 7, 2026
Commentary
I've sold property on California's Central Coast for decades. The buyers chasing ranch and winery estates are after more than a lifestyleplaceholder alt text
By Lindsey HarnJune 6, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.